Journal•ISSN: 1554-7477
Journal of Oncology Practice
American Society of Clinical Oncology
About: Journal of Oncology Practice is an academic journal. The journal publishes majorly in the area(s): Health care & Cancer. It has an ISSN identifier of 1554-7477. Over the lifetime, 2179 publications have been published receiving 35155 citations. The journal is also known as: JCO Oncology Practice.
Topics: Health care, Cancer, MEDLINE, Breast cancer, Guideline
Papers
More filters
[...]
TL;DR: Thirteen categories of breast tumor markers were considered, six of which were new for the guideline, and not all applications for these markers were supported, however.
Abstract: Purpose To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer. Methods For the 2007 update, an Update Committee composed of members from the full Panel was formed to complete the review and analysis of data published since 1999. Computerized literature searches of MEDLINE and the Cochrane Collaboration Library were performed. The Update Committee’s literature review focused attention on available systematic reviews and metaanalyses of published tumor marker studies. In general, significant health outcomes (overall survival, disease-free survival, quality of life, lesser toxicity, and cost-effectiveness) were used for making recommendations. Recommendations and Conclusions
698 citations
[...]
TL;DR: A multifaceted strategy will be needed to ensure that Americans have access to oncology services in 2020, as no single action will fill the likely gap between supply and demand.
Abstract: Purpose To conduct a comprehensive analysis of supply of and demand for oncology services through 2020. This study was commissioned by the Board of Directors of ASCO. Methods New data on physician supply gathered from surveys of practicing oncologists, oncology fellows, and fellowship program directors were analyzed, along with 2005 American Medical Association Masterfile data on practicing medical oncologists, hematologists/oncologists, and gynecologic oncologists, to determine the baseline capacity and to forecast visit capacity through 2020. Demand for visits was calculated by applying age-, sex-, and time-from-diagnosis-visit rate data from the National Cancer Institute's analysis of the 1998 to 2002 Surveillance, Epidemiology and End Results (SEER) database to the National Cancer Institute's cancer incidence and prevalence projections. The cancer incidence and prevalence projections were calculated by applying a 3-year average (2000–2002) of age- and sex-specific cancer rates from SEER to the US Cens...
454 citations
[...]
TL;DR: ASCO's update to its antiemetics guideline now includes an evaluation of evidence on complementary antiemetic therapy.
Abstract: ASCO's update to its antiemetics guideline now includes an evaluation of evidence on complementary antiemetic therapy.
444 citations
[...]
TL;DR: ASCO and CAP collaborated to produce an evidence-based guideline on estrogen and progesterone receptor testing in breast cancer to produce optimal testing performance.
Abstract: ASCO and CAP collaborated to produce an evidence-based guideline on estrogen and progesterone receptor testing in breast cancer to produce optimal testing performance.
415 citations
[...]
409 citations